Friday 6 November 2026 Export RYTM’s income statement to Excel — free account

Rhythm Pharmaceuticals, Inc.

Rhythm Pharmaceuticals, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $189.8 million, up 45.8% from fiscal 2024.

Revenue: +79.6%
EPS: +26.9%
Free cash flow: +95.4%

Quarter to September 2026, against a year earlier

Revenue growth 3 yrs

112.38 7.36 +7.01%

Follow RYTM

Alert me

Market cap: $7.3B
P/E: 0.0×
Fwd P/E: −31.6×
Dividend yield: —
F-score: 6/9
Altman Z: 15.89
Beneish M: −2.93
Dividend safety: n/a

Overview Business Profile Earnings & Analysis Segments Valuation Filings

	Older periods	Dec '25	Mar '26	Jun '26	Sep '26
Piotroski F-Score Full definition →	+8 more TTM periods Free account	6	5	4	4
ROE Full definition →		(251.14%)	(293.04%)	(461.65%)	(167.49%)
ROA Full definition →		(46.29%)	(50.14%)	(51.91%)	(41.75%)
ROIC Full definition →		0.00%	0.00%	0.00%	0.00%
Return on Tangible Assets Full definition →		(55.77%)	(63.37%)	(69.36%)	(73.70%)
Average Days of Receivables Full definition →		50.17	57.47	61.47	50.86
Free Cash Flow per Share Full definition →		(2.42)	(1.76)	(1.54)	(1.18)
Free Cash Flow Full definition →		(157.13)	(119.51)	(105.35)	(81.79)
Capital Expenditures Full definition →		(41.45)	—	—	—
Other line items
Cash ROIC Full definition →		(23.84%)	(20.67%)	(19.22%)	(15.65%)
Accounts Receivable Turnover Full definition →		8.51	8.35	7.21	7.78
Accounts Payable Turnover Full definition →		1.48	1.90	1.64	2.72
Inventory Turnover Full definition →		0.88	0.96	1.07	1.24
Average Days of Payables Full definition →		261.17	195.17	223.59	118.00
Days of Inventory on Hand Full definition →		482.24	454.66	422.10	344.36
Tax Rate Full definition →		0.00	0.00	0.01	0.01
Research and Development Expense of Revenue Full definition →		88.19%	79.24%	72.20%	64.00%
Selling, General and Administrative Expense of Revenue Full definition →		102.73%	101.05%	100.43%	90.93%
Share Based Compensation of Revenue Full definition →		35.21%	35.48%	36.36%	33.28%
Interest Coverage Full definition →		(9.33)	(9.99)	(10.86)	(10.27)
Operating CF/Net income Full definition →		0.57	0.58	0.50	0.41
Depreciation/Fixed assets Full definition →		1.21	1.13	10.48	1.80
Capex/Depreciation Full definition →		(30.98)	0.00	0.00	0.00
Revenue per Share Full definition →		2.92	3.19	3.50	4.07
Operating CF per Share Full definition →		(1.78)	(1.76)	(1.54)	(1.18)
Capex per Share Full definition →		(0.64)	0.00	0.00	0.00
Capex to Sales Full definition →		0.22	0.00	0.00	0.00

Show all line items

Columns are period end dates · fundamentals updated 5 Nov 2026

Stockrow Weekly